C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
---|
ABS | ESOT | | | DRUG 2017-1 (USD 150m) | DRI Capital Inc | | USOA | Jun 5, 2017 | | Class | CCY | SIZE (M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | IPT | GDNC | SPRD | CPN | YLD | PRICE |
---|
E2 | WPE | 55.000 | 6.55 | - | JJJ | - | - | ZZZ | - | - | Ygvai | - | - | - | - | 3.60% | 3.625% | 89.73329 | R1 | VQC | 36.000 | 3.19 | - | HHH | - | - | GGG | - | - | Sxxdtqal | 3eI | - | - | 250 | 3hB+250 | - | 973.00000 |
Tranche Comments R1: Registration: 144R Lfpr;
E2: Registration: 144V Idtb; |
|